CRONOS GROUP INC. (CRON) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $632.07M; Additional Paid in CapitalUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-55.72M; Retained Earnings (Accumulated Deficit)USD $492.32M.
- 2026-03-31: Common Stock, Value, IssuedUSD $647.04M; Additional Paid in CapitalUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-33.92M; Retained Earnings (Accumulated Deficit)USD $460.54M.
- 2025-12-31: Common Stock, Value, IssuedUSD $662.98M; Additional Paid in CapitalUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-16.84M; Retained Earnings (Accumulated Deficit)USD $447.76M.
- 2025-09-30: Common Stock, Value, IssuedUSD $666.15M; Additional Paid in CapitalUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-33.67M; Retained Earnings (Accumulated Deficit)USD $450.03M.
CRONOS GROUP INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Business Combination USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Accumulated Other Comprehensive Income CAD | Noncontrolling Interests CAD | Retained Earnings CAD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $632.07M | (m) | $-55.72M | $492.32M | $1.07B | $1.12B | 3 month · $856.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $647.04M | (m) | $-33.92M | $460.54M | $1.07B | $1.12B | 3 month · $-181.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $662.98M | (m) | $-16.84M | $447.76M | $1.09B | $1.14B | 12 month · $2.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $666.15M | (m) | $-33.67M | $450.03M | $1.08B | $1.13B | 3 month · $1.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $666.61M | (m) | $-8.40M | $424.08M | $1.08B | $1.13B | 3 month · $1.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $669.04M | (m) | $-66.45M | $463.82M | $1.07B | $1.11B | 3 month · $-858.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $669.88M | (m) | $-63.52M | $457.71M | $1.06B | $1.11B | 12 month · $7.62M | 12 month · $53.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $616.40M | $51.52M | $-361.00K | $414.00M | $1.08B | $1.13B | 3 month · $2.25M | 3 month · $53.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $616.38M | $49.30M | $-12.01M | $405.65M | $1.06B | $1.06B | 3 month · $1.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $615.62M | $48.05M | $-1.79M | $414.48M | $1.08B | $1.07B | 3 month · $1.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $662.17M | $48.45M | $20.68M | $416.72M | $1.10B | $1.10B | 12 month · $8.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $613.29M | $47.13M | $-2.11M | $461.51M | $1.12B | $1.12B | 3 month · $1.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $613.15M | $45.32M | $18.07M | $463.15M | $1.14B | $1.14B | 3 month · $2.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $612.24M | $44.04M | $1.54M | $471.51M | $1.13B | $1.13B | 3 month · $2.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $611.32M | $42.68M | $-797.00K | $490.68M | $1.14B | $1.14B | 12 month · $14.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $605.23M | $38.32M | $-18.98M | $569.57M | $1.19B | $1.19B | 3 month · $3.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $604.63M | $35.20M | $41.69M | $606.56M | $1.29B | $1.28B | 3 month · $2.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $596.37M | $35.37M | $66.09M | $626.78M | $1.32B | $1.32B | 3 month · $3.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $595.50M | $32.47M | $49.87M | $659.42M | $1.34B | $1.33B | 12 month · $-2.25M | (m) | 12 month · $7.60M | 12 month · $0.00 | 12 month · $1.37M | (m) | (m) | (m) | (m) |
| 2021-09-30 | $586.88M | $30.37M | $48.93M | $793.28M | $1.46B | $1.46B | 3 month · $7.79M | (m) | 3 month · $1.89M 9 month · $5.81M | (m) | 3 month · $343.00K 9 month · $1.03M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $572.86M | $32.37M | $71.73M | $719.59M | $1.40B | $1.39B | 3 month · $2.67M | (m) | 3 month · $1.86M 6 month · $3.93M | 3 month · $701.00K 6 month · $1.14M | 3 month · $345.00K 6 month · $683.00K | (m) | (m) | (m) | (m) |
| 2021-03-31 | $584.91M | $32.09M | $58.14M | $895.50M | $1.57B | $1.57B | 3 month · $5.45M | (m) | 3 month · $2.06M | 3 month · $338.00K | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $569.26M | $34.60M | $43.00M | $1.06B | $1.71B | $1.71B | 12 month · $19.46M | (m) | 12 month · $7.18M | 12 month · $2.86M | 12 month · $2.86M | (m) | (m) | (m) | (m) |
| 2020-09-30 | $566.58M | $32.49M | $-7.82M | $1.18B | $1.77B | $1.76B | (m) | (m) | 3 month · $1.55M 9 month · $5.05M | (m) | 3 month · $349.00K 9 month · $2.51M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $565.21M | $27.05M | $-33.97M | $1.11B | $1.66B | $1.66B | (m) | (m) | 3 month · $1.77M 6 month · $3.50M | 3 month · $776.00K 6 month · $1.48M | 3 month · $345.00K 6 month · $2.16M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $563.16M | $25.48M | $-85.88M | $1.21B | $1.72B | $1.72B | (m) | (m) | 3 month · $1.73M | 3 month · $1.81M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $561.16M | $23.23M | $27.84M | $1.14B | $1.75B | $1.75B | (m) | (m) | 12 month · $11.62M | 12 month · $889.00K | (m) | 12 month · $83.07M | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $1.62B | (m) | (m) | 3 month · $2.89M 9 month · $7.31M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $921.06M | (m) | (m) | 3 month · $2.65M 6 month · $4.42M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $713.35M | (m) | (m) | 3 month · $1.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $175.00M | $11.26M | $-9.87M | $-27.95M | $148.45M | $148.55M | (m) | (m) | 12 month · $8.15M | (m) | (m) | 12 month · $287.00K | 930.00K | 136.00K | -22.71M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $63.73M | (m) | (m) | 12 month · $1.93M | (m) | (m) | (m) | 880.00K | 0.00 | -3.72M |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $22.30M | (m) | (m) | (m) | (m) | (m) | (m) | 1.58M | (m) | -6.21M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |